Track the Jubilant Pharmova Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Jubilant Pharmova Limited has published 44 reports. Market capitalisation: €154.8bn. The latest transaction was filed on 11 March 2026 (Sale). Among the most active insiders: Jubilant Employees Welfare Trust. All data is accessible without an account.
44
Insider Decl.
n/a
Thresholds
€6m
32 ops.
Buy Volume
€52m
10 ops.
Sell Volume
10Σ signal
Buys €6m€52m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,083 of 29,062 companies
46.8
score / 100
Value
39
Quality
55
FCF yld-1.4%
Earn yld2.6%
EV/EBITDA15.1x
ROE6.0%
Gross mgn68%
Net mgn4.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
93,346 shares@ ₹413.59166.2% of flowEquity SharesSEBI:1a3271f2090e7482d1ff188323aeb7fd33214b29
25 of 44 declarations
Acerca de Jubilant Pharmova Limited
Jubilant Pharmova Limited es una empresa centrada en la salud y los productos farmacéuticos, que ofrece soluciones farmacéuticas y servicios de investigación. Cotiza en el mercado XBOM.